ATA Guidelines Tools

Anaplastic Thyroid Cancer

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link:

Contents of this Issue


Page 13 of 13

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Smallridge RC, Ain KB, Asa SL, et al. American yroid Association guidelines for management of patients with anaplastic thyroid cancer. yroid, a Mary Ann Liebert, Inc. publication. 2012;22(11):1104-39. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 For additional copies, order at Copyright © 2015 All rights reserved ATAANA15073a Abbreviations ATC, anaplastic thyroid carcinoma; CD45, protein tyrosine phosphatase receptor type C; CEA, carcinoembryonic antigen; DTC, differentiated thyroid carcinoma; FTC, follicular thyroid carcinoma; IMRT, intensity-modulated radiation therapy; MTC, medullary thyroid carcinoma; NED, no evidence of disease; P53, cellular tumor antigen p53 or tumor protein p53; PAX8, paired box protein Pax 8 or paired box 8; PTC, papillary thyroid carcinoma; RAI, radioactive iodine; RT, radiation therapy; SCC, squamous cell carcinoma; TTF-1, thyroid transcription factor 1; IV, intravenous American yroid Association, Inc. 6066 Leesburg Pike, Suite 550 • Falls Church, Virginia 22041 Phone: 703.998.8890 • Fax: 703.998.8893 • Physician referral, patient resources available online in English and Spanish.

Articles in this issue

Links on this page

Archives of this issue

view archives of ATA Guidelines Tools - Anaplastic Thyroid Cancer